← k3vl4r
Log inGet started →

MD (Pediatrix Medical Group Inc) Price Forecast

AI-generated price forecast for Pediatrix Medical Group Inc (MD) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of September 2026: K3vl4r's AI model currently reads MD as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 25.93. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

25.93

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

MD forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~13 days out———
Daily~3 months out▼ Down-33.21%—
Weekly~1.8 years out▼ Down-31.03%—

Latest MD news

From the market-news feed the forecasts are read against.

  • Pediatrix (MD) Grows Earnings Even As Patient Volumes Keep Falling · Yahoo · Sep 16
  • Midland Exploration (CVE:MD) Hits New 1-Year Low – Here’s Why · ldr:tickerreport.com · Sep 15
  • 3 Stocks Under $50 with Questionable Fundamentals · Yahoo · Sep 14
  • Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue? · Zacks · Sep 3
  • Q2 Earnings Highlights: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Healthcare Providers & Services Stocks · StockStory · Aug 26

🔒

See the full MD forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

MD forecast — frequently asked

Will MD go up?

K3vl4r's AI model currently reads MD as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the MD price prediction for 2026?

K3vl4r's model projects MD toward $25.84 over the next ~3 months, a -0.3% move from $25.93. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could MD reach?

Over its longest horizon (~~1.8 years), the model's projected target for MD is $25.61 (-0.3% vs $25.69). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

HUMAEELVEOLSEMBCCBUSAVTXJBIOTVRDCODXIMVTSNDXTFXMGNXSENS

Will MD reach…?

Will MD reach $50.00?Will MD reach $100.00?Will MD reach $200.00?

Or see the full MD price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare MD

MD vs HUMAMD vs EELVMD vs EOLSMD vs EMBCMD vs CBUSMD vs AVTX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.